Eton Pharmaceutcials
ETON
103 hedge funds and large institutions have $398M invested in Eton Pharmaceutcials in 2025 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 26 increasing their positions, 28 reducing their positions, and 11 closing their positions.
763% more call options, than puts
Call options by funds: $2.44M | Put options by funds: $282K
145% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 11
64% more capital invested
Capital invested by funds: $243M → $398M (+$155M)
18% more funds holding
Funds holding: 87 → 103 (+16)
4.17% more ownership
Funds ownership: 63.66% → 67.83% (+4.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$7.87M |
| 2 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$3.19M |
| 3 |
LK
Lumbard & Kellner
Hollis,
New Hampshire
|
+$2.93M |
| 4 |
BlackRock
New York
|
+$2.87M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$2.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.08M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$3.31M |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
-$1.54M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.41M |
| 5 |
Renaissance Technologies
New York
|
-$1.35M |
ETON Hedge Fund Activity: Q3 2025 in Review
103 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q3 2025, worth a combined $398M — up 64% from $243M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new ETON positions and 11 closed out — a net gain of 16 holders — while 26 added to existing stakes and 28 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $7.87M. The largest seller was Acadian Asset Management, cutting an estimated $6.08M.
- 103 institutional investors held Eton Pharmaceutcials (ETON) as of Q3 2025, up from 87 in Q2 2025.
- Funds reported $398M of Eton Pharmaceutcials stock for Q3 2025, up 64% quarter-over-quarter.
- 27 funds opened new Eton Pharmaceutcials positions in Q3 2025 and 11 closed out, a net change of +16 holders.
- The largest Eton Pharmaceutcials buyer in Q3 2025 was Royal Bank of Canada, an estimated $7.87M added.
- The largest Eton Pharmaceutcials seller in Q3 2025 was Acadian Asset Management, an estimated $6.08M sold.
Based on aggregated 13F filings for Q3 2025.